NO962244L - Fremgangsmåte for forhöyelse av stabiliteten av liposom-suspensjoner inneholdende hydrofile aktive materialer - Google Patents

Fremgangsmåte for forhöyelse av stabiliteten av liposom-suspensjoner inneholdende hydrofile aktive materialer

Info

Publication number
NO962244L
NO962244L NO962244A NO962244A NO962244L NO 962244 L NO962244 L NO 962244L NO 962244 A NO962244 A NO 962244A NO 962244 A NO962244 A NO 962244A NO 962244 L NO962244 L NO 962244L
Authority
NO
Norway
Prior art keywords
stability
increasing
active materials
containing hydrophilic
suspensions containing
Prior art date
Application number
NO962244A
Other languages
English (en)
Norwegian (no)
Other versions
NO962244D0 (no
Inventor
Andreas Sachse
Georg Rossling
Jens Leike
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO962244L publication Critical patent/NO962244L/no
Publication of NO962244D0 publication Critical patent/NO962244D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO962244A 1993-12-02 1996-05-31 Fremgangsmåte for forhöyelse av stabiliteten av liposom-suspensjoner inneholdende hydrofile aktive materialer NO962244D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4341472A DE4341472A1 (de) 1993-12-02 1993-12-02 Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
PCT/EP1994/003964 WO1995015153A1 (fr) 1993-12-02 1994-11-30 Procede permettant d'augmenter la stabilite de suspensions de liposomes contenant des principes actifs hydrophiles

Publications (2)

Publication Number Publication Date
NO962244L true NO962244L (no) 1996-05-31
NO962244D0 NO962244D0 (no) 1996-05-31

Family

ID=6504253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962244A NO962244D0 (no) 1993-12-02 1996-05-31 Fremgangsmåte for forhöyelse av stabiliteten av liposom-suspensjoner inneholdende hydrofile aktive materialer

Country Status (9)

Country Link
US (1) US6475515B2 (fr)
EP (1) EP0731689A1 (fr)
JP (1) JPH09505821A (fr)
AU (1) AU1241695A (fr)
CA (1) CA2177973A1 (fr)
DE (1) DE4341472A1 (fr)
HU (1) HUT75465A (fr)
NO (1) NO962244D0 (fr)
WO (1) WO1995015153A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416149D0 (en) * 1994-08-10 1994-09-28 Univ Strathclyde Vesicle formulation
DE4430592A1 (de) * 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
DE19606326A1 (de) * 1995-02-09 1996-08-22 Schering Ag Kontrastmittelhaltige Liposomenformulierung sowie deren Verwendung für die In-vivo-Diagnostik, insbesondere für die Darstellung des Intravasalraumes
DE19529922A1 (de) * 1995-08-01 1997-02-06 Schering Ag Verwendung von liposomalen Zubereitungen in der indirekten MRT-Lymphographie
AU2158401A (en) * 1999-11-05 2001-05-14 Seed Capital Investments-2 (Sci-2) B.V. Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained
US8357351B2 (en) * 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JPWO2006009022A1 (ja) * 2004-07-21 2008-05-01 コニカミノルタエムジー株式会社 リポソーム含有ｘ線造影剤およびその製造方法
WO2006100692A2 (fr) * 2005-03-21 2006-09-28 Lifecare Innovations Pvt. Ltd. Nouvelle composition vesiculaire inter et intra multilamellaire
MX2007015577A (es) * 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
WO2007026151A1 (fr) * 2005-09-01 2007-03-08 Biolipox Ab Composition de liposome contenant un antihistaminique et un corticosteroide et son utilisation pour la fabrication d'un medicament pour traiter la rhinite et les troubles associes
CA2708028A1 (fr) * 2007-12-05 2009-06-11 Marval Biosciences, Inc. Agents de contraste d'echelle nanometrique et procedes d'utilisation
WO2009152445A1 (fr) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imagerie de plaques d’athérosclérose utilisant des agents d’imagerie de liposomes
EP2773325B1 (fr) * 2011-11-04 2018-09-19 Enceladus Pharmaceuticals B.V. Corticostéroïdes liposomaux pour le traitement des affections inflammatoires chez l'homme
KR102554628B1 (ko) 2013-02-01 2023-07-12 존원 파마, 인코포레이티드 리포좀 내로 난수용성 약물의 원격 부하
WO2015156904A1 (fr) * 2014-04-08 2015-10-15 Aradigm Corporation Liposomes formant des nanocristaux de médicament suite à congélation-décongélation
AU2015244275B2 (en) 2014-04-08 2019-08-29 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
EP3177269A4 (fr) 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Chargement à distance de médicaments modérément hydrosolubles dans des vésicules lipidiques
JP7079250B2 (ja) * 2016-08-18 2022-06-01 ブレマー，トロイ リポソーム構築物を用いた黄斑細胞及び網膜細胞への尿素の送達
WO2022098801A1 (fr) * 2020-11-03 2022-05-12 Vesselon, Inc. Compositions et procédés pour l'administration ciblée d'agents thérapeutiques utilisant des supports

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
DE68916439T2 (de) * 1988-10-05 1994-10-20 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
IL94718A (en) * 1989-07-05 1994-10-21 Schering Ag Non-ionic carboxamide contrast agent and method of preparation
DE3934656A1 (de) * 1989-10-13 1991-04-18 Schering Ag Verfahren zur herstellung von waessrigen dispersionen
WO1993020802A1 (fr) * 1992-04-09 1993-10-28 Northwestern University Liposomes a reflexion acoustique et procedes de preparation et d'utilisation

Also Published As

Publication number Publication date
AU1241695A (en) 1995-06-19
US6475515B2 (en) 2002-11-05
EP0731689A1 (fr) 1996-09-18
DE4341472A1 (de) 1995-06-08
NO962244D0 (no) 1996-05-31
HUT75465A (en) 1997-05-28
US20020102293A1 (en) 2002-08-01
WO1995015153A1 (fr) 1995-06-08
CA2177973A1 (fr) 1995-06-08
JPH09505821A (ja) 1997-06-10
HU9601476D0 (en) 1996-07-29

Similar Documents

Publication Publication Date Title
NO962244L (no) Fremgangsmåte for forhöyelse av stabiliteten av liposom-suspensjoner inneholdende hydrofile aktive materialer
AU672579B2 (en) Stable aqueous suspension of liposome
DE69323431D1 (de) Herstellung von feststoffmaterialien
DE69506106D1 (de) Herstellung von mehrlagiger wellpappe
NO943093D0 (no) Fremgangsmåte for fremstilling av clavulansyre
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
DE69601673D1 (de) Herstellungsverfahren von Packungen
NO944871D0 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
DE69423179D1 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
DE69301343D1 (de) Selbstlenkende Achse
FI934749A (fi) Foerfarande foer framstaellning av aromatiska brommetylfoereningar
DE69616573D1 (de) Herstellung von suspensionen von vermahltem teilchenförmigem material
DE69315370D1 (de) Herstellung von rauhen Silizium-Oberflächen
DE69610990D1 (de) Herstellung von suspensionen von vermahltem teilchenförmigem material
NO941659L (no) Fremgangsmåte for fremstilling av aluminoksaner
FI941478A0 (fi) Foerbaettrande av kvalitet av Robusta-kaffe
NO955082D0 (no) Fremgangsmåte for fremstilling av glutardialdehyd
AU7176994A (en) Taste-masked acetaminophen suspensions and methods of making the same
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO945013D0 (no) Fremgangsmåte for fremstilling av titandioksyd
ITMI932094A0 (it) Procedimento per la fabbricazione di carta e cartone
NO933264D0 (no) Framgangsmaate for framstilling av ferrosilisium
DE59707175D1 (de) Verwendung von wirkstoffmischungen zur herstellung von hypocholesterinämischen mitteln
FI932887A (fi) Parannettu menetelmä 4-nitro-3-trifluorometyylianiliinin valmistamiseksi
FI920362A0 (fi) Optiskt foerfarande foer bestaemning av en kropps tredimensionell form.